These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 186817)

  • 1. Behavioral depression: thyroid interactions with norepinephrine-depleting drugs.
    Davenport JW; Hennies RS; Carey JC; Bishop SB
    Pharmacol Biochem Behav; 1976 Jul; 5(1):87-9. PubMed ID: 186817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of dopamine-beta-hydroxylase in the regulation of norepinephrine biosynthesis in rat brain.
    Wise CD; Belluzzi JD; Stein L
    Pharmacol Biochem Behav; 1977 Dec; 7(6):549-53. PubMed ID: 201940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of norepinephrine in feeding behavior.
    Rossi J; Zolovick AJ; Davies RF; Panksepp J
    Neurosci Biobehav Rev; 1982; 6(2):195-204. PubMed ID: 6285235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resumption with clonidine of pulsatile LH release following acute norepinephrine depletion in ovariectomized rats.
    Estes KS; Simpkins JW; Kalra SP
    Neuroendocrinology; 1982; 35(1):56-62. PubMed ID: 6287329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine.
    Evans KR; Beninger RJ; Eikelboom R
    Pharmacol Biochem Behav; 1985 Apr; 22(4):535-40. PubMed ID: 3991764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland.
    Blaustein JD; Brown TJ; McElroy JF
    Neuroendocrinology; 1986; 43(2):143-9. PubMed ID: 2873523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of brain norepinephrine in neuroleptic-induced catalepsy in rats.
    Honma T; Fukushima H
    Pharmacol Biochem Behav; 1977 Dec; 7(6):501-6. PubMed ID: 201939
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of brain monoamines in release of gonadotropin before proestrus in the cyclic rat.
    Terasawa E; Bridson WE; Davenport JW; Goy RW
    Neuroendocrinology; 1975; 18(4):345-58. PubMed ID: 1240617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
    Berger T; Lemmer B
    Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of amphetamine-induced behavioural changes in the mouse. III. Effects of apomorphine and Fla 63.
    Thomas KV; Handley SL
    Arzneimittelforschung; 1978; 28(6):993-7. PubMed ID: 582011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic administration of antidepressant drugs on the noradrenaline disappearance induced by FLA-63 in the rat brain.
    Mogilnicka E; Klimek V
    Pol J Pharmacol Pharm; 1979; 31(2):139-47. PubMed ID: 158750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of FLA-63 on pentobarbitone sleep in chicks and rats.
    Wambebe C; Osuide G
    Clin Exp Pharmacol Physiol; 1983; 10(5):555-66. PubMed ID: 6641017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved pharmacological procedure for depletion of noradrenaline: pharmacology and assessment of noradrenaline-associated behaviors.
    Zolovick AJ; Rossi J; Davies RF; Panksepp J
    Eur J Pharmacol; 1982 Feb; 77(4):265-71. PubMed ID: 6916642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone in the pancreas and brain of the rat is regulated by central noradrenergic and dopaminergic pathways.
    Engler D; Chad D; Jackson IM
    J Clin Invest; 1982 Jun; 69(6):1310-20. PubMed ID: 6806317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
    Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
    Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-beta-hydroxylase inhibitors modulate the concentration of functional estrogen receptors in female rat hypothalamus and pituitary gland.
    Blaustein JD; Brown TJ; Swearengen ES
    Neuroendocrinology; 1986; 43(2):150-8. PubMed ID: 3014364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some characteristics of amnesia induced by FLA-63 an inhibitor of dopamine beta hydroxylase.
    Botwinick CY; Quartermain D; Freedman LS; Hallock MF
    Pharmacol Biochem Behav; 1977 May; 6(5):487-91. PubMed ID: 19771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.